Medical Advisory Committee
at Cambridge Heart Clinic
About Dr Fynn
Dr Fynn was appointed a Consultant Cardiologist in 2004 and was awarded membership of the Medical Advisory Committee of Cambridge Heart Clinic in 2008.
Dr Simon Fynn is a Consultant Cardiologist at Royal Papworth Hospital. He is also a member of the Clinical Advisory Group of the Anglia Stroke & Heart Network and is the Network Lead for Electrophysiology.
His training began at the University of Cambridge, where he read medicine at St. John’s College. He undertook specialist training in cardiology in Manchester before spending two years at the Royal Melbourne Hospital, Australia, one of the world’s leading centres in cardiac electrophysiology.
He specialises in the investigation and treatment of cardiac arrhythmias and undertakes radiofrequency catheter ablation. He has a particular interest in the commonest heart rhythm disorder (atrial fibrillation) and received an MD from the University of Cambridge for his research in this field.
In recent times he has led the development of a Family Cardiac Screening Clinic, where family members of those who have suffered a sudden and unexpected cardiac death can be screened for inherited cardiac conditions.
He has published numerous clinical and research papers on the mechanisms and treatment of cardiac arrhythmias, and also on the treatment of cardiac failure using Cardiac Resynchronisation Therapy.
Specialist clinical interests
Arrhythmias, Catheter Ablation, Atrial Fibrillation, Syncope, Inherited Cardiac Conditions.
Atrial Fibrillation, Cardiac Resynchronisation Therapy.
Education and training
BA (Medical Sciences)1988
Member of General Medical Council (Reg. No 3592591)
Member of British Cardiovascular Society
Member of Heart Rhythm UK
Member of British Medical Society
Fellow of the Royal College of Physicians
Declaration of interests
Dr Fynn has declared that he does not hold a share or any financial interest in Cambridge Heart Clinic or any company owned by Regent’s Park Healthcare. This statement conforms with guidance set out by the Competition and Markets Authority.
Areas of Expertise
Research & Articles
An entirely subcutaneous implantable cardioverter-defibrillator.
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. N Engl J Med. 2010 Jul 1;363(1):36-44.
Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy.
Scharf C, Boersma L, Davies W, Kanagaratnam P, Peters NS, Paul V, Rowland E, Grace A, Fynn SP, Dang L, Oral H, Morady F. J Am Coll Cardiol. 2009 Oct 6;54(15):1450-6.
Khan FZ, Virdee MS, Gopalan D, Rudd J, Watson T, Fynn SP, Dutka DP.
Characterization of the suitability of coronary venous anatomy for targeting left ventricular lead placement in patients undergoing cardiac resynchronization therapy. Europace. 2009 Nov;11(11):1491-5. PubMed PMID: 19880411.
P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin.
Kistler PM, Roberts-Thomson KC, Haqqani HM, Fynn SP, Singarayar S, Vohra JK, Morton JB, Sparks PB, Kalman JM. J Am Coll Cardiol. 2006 Sep 5;48(5):1010-7.
Dr Simon Fynn
Cambridge Heart Clinic
Cambridge University Hospitals
NHS Foundation Trust,
Cambridge, United Kingdom
Tel: +44 (0)1223 857474